The purposes of this article are 1) to review federal and state laws relevant to confidentiality in group therapy with impaired physicians and 2) to provide empirical data concerning the actual confidentiality practices and experiences of group therapists treating chemically impaired physicians.
In the clinical research phase, 25 state medical societies identified 45 rehabilitation centers as those to which the societies preferentially referred chemically impaired physicians.
Fifty-one group leaders from 33 ofthese rehabilitation centers completed the survey questionnaire employed in this project.
Because of the risk of potentially irreversible social and professional injury, physician patients were exceedingly concerned about breaches of confidentiality.
Co-members'infractions most often involved the violator sharing with close friends and family members the name and abuse history ofa fellow physician.
In contrast, transgressors rarely leaked information about a co-member's drug-related illegal behavior.
Chemically impaired physicians would feel safer in sharing secrets in group therapy if more jurisdictions adopted legislation making co-members liable for violating confidentiality.
Currently the pertinent body of law is confusing and inconsistent and provides little protection to impaired physicians who enter group therapy.
The authors propose ideas for model legislation.
Mots-clés Pascal : Toxicomanie, Alcoolisme, Médecin, Psychothérapie groupe, Sevrage toxique, Traitement, Secret medical, Confidentialité, Législation, Etats Unis, Amérique du Nord, Amérique, Homme
Mots-clés Pascal anglais : Drug addiction, Alcoholism, Physician, Group psychotherapy, Poison withdrawal, Treatment, Medical confidentiality, Confidentiality, Legislation, United States, North America, America, Human
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 96-0457871
Code Inist : 002B18I15. Création : 10/04/1997.